Treating mice with rapamycin, an mTOR inhibitor, Halloran et al. observed reduced anxiety-like behavior, e.g., reduced thigmotaxis (swimming in close proximity to the pool wall), in mice with AD-like pathology. This evidence concerns the gene MTOR and Alzheimer disease.